Investor Information

IR banner
Webcast ImageWebcast - Replay
Q2 2016 Express Scripts Holding Co Earnings Conference Call
07/26/16 at 8:30 a.m. ET
Q2 2016 Express Scripts Holding Co Earnings Conference Call
Tuesday, July 26, 2016 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Business Overview

Business Overview
At Express Scripts we believe in practicing pharmacy smarter. We put medicine within reach of tens of millions of people by aligning with our customers, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

Stock chart for: ESRX.O.  Currently trading at $76.07 with a 52 week high of $94.22 and a 52 week low of $65.55.
ESRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$76.07
Change (%) Stock is Down 1.02 (1.32%)
Volume4,550,675
Data as of 07/29/16 4:00 p.m. ET
Refresh quote
Recent Press Releases
Express Scripts Announces Final Results of Maximum Tender Offers - 07/28/2016 - 9:15 a.m.
ST. LOUIS, Mo., July 28, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the final tender results for its previously announced ... 
Express Scripts Announces 2016 Second Quarter Results; Narrows 2016 Full-Year Adjusted Diluted EPS Guidance Range; Raises Mid-Point; Provides 2016 Third Quarter Guidance - 07/25/2016 - 4:02 p.m.
ST. LOUIS, July 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 second quarter net income of $720.7 million, or $1.13 per diluted share.  2016 second quarter adj... 
Express Scripts Announces Early Tender Results and Upsizing of Maximum Tender Offers - 07/23/2016 - 12:47 p.m.
ST. LOUIS, July 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the early tender results for its previously announced tende... 
Express Scripts Announces Pricing of Maximum Tender Offers - 07/14/2016 - 6:15 p.m.
ST. LOUIS, July 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the consideration payable in connection with its previously... 
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Express Scripts Holding Co posts new information to the site. Just enter your e-mail address and click Submit.
 

Tax Consequences of Express Scripts and Medco Merger

Investor Overview
Learn more about Express Scripts and find corporate and shareholder information.

Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print | E-mail Page E-mail Page | RSS Feeds RSS | E-mail Alerts Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet